Oxbridge Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement

Core Viewpoint - Oxbridge Re Holdings Limited has announced a securities purchase agreement to raise approximately $3.0 million through a registered direct offering and a concurrent private placement of ordinary shares and warrants [1][2]. Group 1: Offering Details - The company will sell 705,884 ordinary shares at an effective offering price of $4.25 per share, along with Series A and Series B Warrants [1]. - The Series A Warrants are immediately exercisable with an exercise price of $4.25 and will expire two years from the initial exercise date [1]. - The Series B Warrants will be exercisable upon shareholder approval or six months from issuance, with an exercise price based on the lower of the Nasdaq minimum price or $4.25 after shareholder approval [1]. Group 2: Financial Proceeds - The estimated gross proceeds from the offering are approximately $3.0 million before deducting fees and expenses [2]. - The offering is expected to close on or about February 26, 2025, pending customary closing conditions [2]. Group 3: Regulatory Information - The ordinary shares are being offered under a shelf registration statement declared effective by the SEC on September 6, 2022 [3]. - A prospectus supplement will be filed with the SEC for the registered direct offering [3]. Group 4: Company Overview - Oxbridge Re Holdings Limited specializes in tokenized Real-World Assets (RWAs) and provides reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States [6][7]. - The company's subsidiary, SurancePlus Inc., has developed the first "on-chain" reinsurance RWA, making reinsurance more accessible to both U.S. and non-U.S. investors [8].